Penta-O-galloyl-β-D-glucose suppresses prostate cancer bone metastasis by transcriptionally repressing EGF-induced MMP-9 expression

Journal of Agricultural and Food Chemistry

Volumn 57, Issue 8, 2009, Pages 3331-3339

  Kuo, Po Tsun ^a,b,c,d   Lin, Tsung Pang ^a,b,c,d   Liu, Liang Chih ^a,b,c,d   Huang, Chi Hung ^a,b,c,d   Lin, Jen Kun ^a,b,c,d   Kao, Jung Yie ^a,b,c,d   Way, Tzong Der ^a,b,c,d  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c FENG YUAN HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

5GG; EGFR; Invasion; JNK; MMP 9; Prostate cancer

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GELATINASE B; GLUCOSE PENTAGALLATE; MESSENGER RNA; TANNIN;

ANIMAL; ARTICLE; BONE TUMOR; CANCER INVASION; CANCER TRANSPLANTATION; DOWN REGULATION; DRUG EFFECT; ENZYMOLOGY; GENETIC TRANSCRIPTION; GENETICS; HUMAN; MALE; METASTASIS; MOUSE; NUDE MOUSE; PATHOLOGY; PROSTATE TUMOR; SECRETION; TUMOR CELL LINE;

ANIMALS; BONE NEOPLASMS; CELL LINE, TUMOR; DOWN-REGULATION; EPIDERMAL GROWTH FACTOR; HUMANS; HYDROLYZABLE TANNINS; MALE; MATRIX METALLOPROTEINASE 9; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; PROSTATIC NEOPLASMS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

MUS MUSCULUS;

EID: 65349163593     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf803725h     Document Type: Article

References (30)

1. Smith, R. A.; Cokkinides, V.; Brawley, O. W. Cancer screening in the United States, 2009: A review of current American Cancer Society guidelines and issues in cancer screening. Ca -Cancer J. Clin. 2009, 59, 27-41.
2. Griffiths, K.; Eaton, C. L.; Harper, M. E.; Turkes, A.; Peeling, W. B. Hormonal treatment of advanced disease: some newer aspects. Semin. Oncol. 1994, 21, 672-687.
3. Nemeth, J. A.; Yousif, R.; Herzog, M.; Che, M.; Upadhyay, J.; Shekarriz, B.; Bhagat, S.; Mullins, C; Fridman, R.; Cher, M. L. Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis. J. Natl. Cancer Inst. 2002, 94, 17-25.
4. Moses, M. A.; Wiederschain, D.; Loughlin, K. R.; Zurakowski, D.; Lamb, C. C; Freeman, M. R. Increased incidence of matrix metalloproteinases in urine of cancer patients. Cancer Res. 1998, 58, 1395-1399.
5. Kong, D.; Li, Y.; Wang, Z.; Banerjee, S.; Sarkar, F. H. Inhibition of angiogenesis and invasion by 3,3'-diindolylmethane is mediated by the nuclear factor-kappaB downstream target genes MMP-9 and uPA that regulated bioavailability of vascular endothelial growth factor in prostate cancer. Cancer Res. 2007, 67, 3310-3319.
6. Kim, S. J.; Uehara, H.; Yazici, S.; Langley, R. R.; He, J.; Tsan, R.; Fan, D.; Killion, J. J.; Fidler, I. J. Simultaneous blockade of platelet-derived growth factor-receptor and epidermal growth factor-receptor signaling and systemic administration of paclitaxel as therapy for human prostate cancer metastasis in bone of nude mice. Cancer Res. 2004, 64, 4201-4208.
7. Hou, X.; Johnson, A. C; Rosner, M. R. Induction of epidermal growth factor receptor gene transcription by transforming growth factor beta 1: association with loss of protein binding to a negative regulatory element. Cell Growth Differ. 1994, 5, 801-809.
8. Chung, L. W.; Baseman, A.; Assikis, V.; Zhau, H. E. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment. J. Urol. 2005, 173, 10-20.
9. Dorai, T.; Dutcher, J. P.; Dempster, D. W.; Wiernik, P. H. Therapeutic potential of curcumin in prostate cancer-V: Interference with the osteomimetic properties of hormone refractory C4-2B prostate cancer cells. Prostate 2004, 60, 1-17.
10. Gonzalez, E. A.; Disthabanchong, S.; Kowalewski, R.; Martin, K. J. Mechanisms of the regulation of EGF receptor gene expression by calcitriol and parathyroid hormone in UMR 106-01 cells. Kidney Int. 2002, 61, 1627-1634.
11. Fujiki, H. Green tea: Health benefits as cancer preventive for humans. Chem. Rec. 2005, 5, 119-132.
12. Huh, J. E.; Lee, E. O.; Kim, M. S.; Kang, K. S.; Kim, C. H; Cha, B. C.; Surh, Y. J.; Kim, S. H. Penta-O-galloyl-beta-D-glucose suppresses tumor growth via inhibition of angiogenesis and stimulation of apoptosis: roles of cyclooxygenase-2 and mitogen-activated protein kinase pathways. CarcìnoQenesìs 2005, 26, 1436-1445.
13. Hu, H; Lee, H. J.; Jiang, C.; Zhang, J.; Wang, L; Zhao, Y.; Xiang, Q.; Lee, E. O.; Kim, S. H.; Lü, J. Penta-1,2,3,4,6-O-galloyl-beta-D-glucose induces p53 and inhibits STAT3 in prostate cancer cells in vitro and suppresses prostate xenograft tumor growth in vivo. Mol. Cancer Ther. 2008, 7, 2681-2691.
14. Ho, L. L; Chen, W. J.; Lin-Shiau, S. Y.; Lin, J. K. Penta-O-galloyl-beta- D-glucose inhibits the invasion of mouse melanoma by suppressing metalloproteinase-9 through down-regulation of activator protein-1. Eur. J. Pharmacol. 2002, 453, 149-158.
15. Yokozawa, T.; Chung, H. Y.; Oura, H; Nonaka, G.; Nishioka, I. Isolation of a renal function-facilitating constituent from the Oriental drug, salviae miltiorrhizae radix. NÌon Jinzo Gakkaishi 1989, 31, 1091-1098.
16. Westermarck, J.; Kahari, V. M. Regulation of matrix metallo-proteinase expression in tumor invasion. FASEB J. 1999, 13, 781- 792.
17. Uzzo, R. G.; Crispen, P. L.; Golovine, K.; Makhov, P.; Horwitz, E. M.; Kolenko, V. M. Diverse effects of zinc on NF-kappaB and AP-1 transcription factors: implications for prostate cancer progression. Carcì noQenesìs 2006, 27, 1980-1990.
18. Shukla, S.; Maclennan, G. T.; Marengo, S. R.; Resnick, M. I.; Gupta, S. Constitutive activation of P I3 K-Akt and NF-kappaB during prostate cancer progression in autochthonous transgenic mouse model. Prostate 2005, 64, 224-239.
19. Alwan, H. A.; van Zoelen, E. J.; van Leeuwen, J. E. Ligand-induced lysosomal epidermal growth factor receptor (EGFR) degradation is preceded by proteasome-dependent EGFR de-ubiquitination. J. Biol. Chem. 2003, 278, 35781-35790.
20. Mundy, G. R. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat. Rev. Cancer 2002, 2, 584-593.
21. Roato, L; D?melio, P.; Gorassini, E.; Grimaldi, A.; Bonello, L.; Fiori, C; Delsedime, L.; Tizzani, A.; De Libero, A.; Isaia, G.; Ferracini, R. Osteoclasts are active in bone forming metastases of prostate cancer patients. PLoS One 2008, 3, e3627.
22. Zellweger, T.; Ninck, C; Bloch, M.; Mirlacher, M.; Koivisto, P. A.; Helin, H. J.; Mihatsch, M. J.; Gasser, T. C; Bubendorf, L. Expression patterns of potential therapeutic targets in prostate cancer. Int. J. Cancer 2005, 113, 619-628.
23. Adam, R. M.; Kim, J.; Lin, J.; Orsola, A.; Zhuang, L.; Rice, D. C; Freeman, M. R. Heparin-binding epidermal growth factor-like growth factor stimulates androgen-independent prostate tumor growth and antagonizes androgen receptor function. Endocrinology 2002, 143, 4599-4608.
24. Freeman, M. R. HER2/HER3 heterodimers in prostate cancer: Whither HER1/EGFR? Cancer Cell 2004, 6, 427-428.
25. Festuccia, C; Guerra, F.; D?scenzo, S.; Giunciuglio, D.; Albin, i A.; Bologna, M. In vitro regulation of pericellular proteolysis in prostatic tumor cells treated with bombesin. Int. J. Cancer 1998, 75b, 418-431.
26. Shukla, S.; Gupta, S. Suppression of constitutive and tumor necrosis factor alpha-induced nuclear factor (NF)-kappaB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: correlation with down-regulation of NF-kappaB-responsive genes. Clìn. Cancer Res. 2004, 10, 3169-3178.
27. Andela, V. B.; Gordon, A. H.; Zotalis, G.; Rosier, R. N.; Goater, J. J.; Lewis, G. D.; Schwarz, E. M.; Puzas, J. E.; O'Keefe, R. J. NFkappaB: a pivotal transcription factor in prostate cancer metastasis to bone. Clìn. Orthov. Relat. Res. 2003, 415, S75-S85, Suppl.
28. Lee, F. S.; Hagler, J.; Chen, Z. J.; Maniatis, T. Activation of the IkappaB alpha kinase complex by MEKK1, a kinase of the JNK pathway. Çeg 1997, 88, 213-222.
29. Jarrard, D. F.; Blitz, B. F.; Smith, R. C; Patai, B. L; Rukstahs, D.B. Effect of epidermal growth factor on prostate cancer cell line PC3 growth and invasion. Prostate 1994, 24, 46-53.
30. Seth, D.; Shaw, K.; Jazayeri, J.; Leedman, P. J. Complex post-transcriptional regulation of EGF-receptor expression by EGF and TGF-alpha in human prostate cancer cells. Br. J. Cancer 1999, 80, 657-669.